Assessing the public health risk of shiga toxin-producing escherichia coli by use of a rapid diagnostic screening algorithm

Journal of Clinical Microbiology

Volumn 53, Issue 5, 2015, Pages 1588-1598

  De Boer, Richard F ^a,b   Ferdous, Mithila ^c   Ott, Alewijn ^b,c   Scheper, Henk R ^b   Wisselink, Guido J ^a   Heck, Max E ^d   Rossen, John W ^c   Kooistra Smid, Anna M D ^a,b,c  

^a Department of Medical Microbiology   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AAT GENE; ADULT; AGGR GENE; ALGORITHM; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BFPA GENE; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI INFECTION; ESCV GENE; FECES ANALYSIS; FEMALE; GASTROINTESTINAL SYMPTOM; GENE IDENTIFICATION; HEALTH HAZARD; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH; RAPID TEST; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; STX GENE; ADOLESCENT; AGED; CHEMISTRY; CHILD; CLASSIFICATION; CULTURE MEDIUM; ESCHERICHIA COLI INFECTIONS; EVALUATION STUDY; FECES; GENETICS; INFANT; ISOLATION AND PURIFICATION; MASS SCREENING; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PROCEDURES; SEROTYPING; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ESCHERICHIA COLI;

CULTURE MEDIUM; O ANTIGEN; VIRULENCE FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BACTERIOLOGICAL TECHNIQUES; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MASS SCREENING; MIDDLE AGED; O ANTIGENS; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEROTYPING; SHIGA-TOXIGENIC ESCHERICHIA COLI; TIME FACTORS; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84928036907     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03590-14     Document Type: Article

References (51)

1. Paton JC, Paton AW. 1998. Pathogenesis and diagnosis of Shiga toxinproducing Escherichia coli infections. Clin Microbiol Rev 11:450-479.
2. Griffin PM, Tauxe RV. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. Coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 13:60-98.
3. Gyles CL. 2007. Shiga toxin-producing Escherichia coli: an overview. J Anim Sci 85:E45-62. http://dx.doi.org/10.2527/jas.2006-508.
4. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat Rev Microbiol 2:123-140. http://dx.doi.org/10.1038/nrmicro818.
5. Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, Isaac-Renton J, Clark C, Rahn K, Kaper JB. 2003. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxinproducing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 41:4930-4940. http://dx.doi.org/10.1128/JCM.41.11.4930-4940.2003.
6. Karmali MA. 1989. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 2:15-38.
7. Rangel JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL. 2005. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982 to 2002. Emerg Infect Dis 11:603-609. http://dx.doi.org/10.3201/eid1104 .040739.
8. Scientific Opinion of the Panel on Biological Hazards. 2007. Monitoring of verotoxigenic Escherichia coli (VTEC) and identification of human pathogenic VTEC types. EFSA J 579:1-61.
9. EFSA Panel on Biological Hazards. 2013. Scientific opinion on VTECseropathotype and scientific criteria regarding pathogenicity assessment. EFSA J 11:3138.
10. Bielaszewska M, Mellmann A, Zhang W, Kock R, Fruth A, Bauwens A, Peters G, Karch H. 2011. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 11:671-676. http://dx.doi.org/10.1016/S1473-3099(11)70165-7.
11. Piérard D, De Greve H, Haesebrouck F, Mainil J. 2012. O157:H7 and O104:H4 Vero/Shiga toxin-producing Escherichia coli outbreaks: respecdetive role of cattle and humans. Vet Res 43:13. http://dx.doi.org/10.1186/1297-9716-43-13.
12. Prager R, Annemuller S, Tschape H. 2005. Diversity of virulence patterns among Shiga toxin-producing Escherichia coli from human clinical casesneed for more detailed diagnostics. Int J Med Microbiol 295:29-38. http://dx.doi.org/10.1016/j.ijmm.2004.12.009.
13. Schmidt MA. 2010. LEEways: tales of EPEC, ATEC and EHEC. Cell Microbiol 12:1544-1552. http://dx.doi.org/10.1111/j.1462-5822.2010 .01518.x.
14. Karch H, Schubert S, Zhang D, Zhang W, Schmidt H, Olschlager T, Hacker J. 1999. A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages. Infect Immun 67:5994-6001.
15. Makino S, Tobe T, Asakura H, Watarai M, Ikeda T, Takeshi K, Sasakawa C. 2003. Distribution of the secondary type III secretion system locus found in enterohemorrhagic Escherichia coli O157:H7 isolates among Shiga toxin-producing E. Coli strains. J Clin Microbiol 41:2341-2347. http://dx.doi.org/10.1128/JCM.41.6.2341-2347.2003.
16. Brunder W, Schmidt H, Frosch M, Karch H. 1999. The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements. Microbiology 145 (Part 5):1005-1014.
17. Bugarel M, Martin A, Fach P, Beutin L. 2011. Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiol 11:142. http://dx.doi.org/10.1186/1471-2180-11-142.
18. Newton HJ, Sloan J, Bulach DM, Seemann T, Allison CC, Tauschek M, Robins-Browne RM, Paton J C, Whittam TS, Paton AW, Hartland EL. 2009. Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacement. Emerg Infect Dis 15:372-380. http://dx.doi.org/10 .3201/eid1502.080631.
19. Iyoda S, Tamura K, Itoh K, Izumiya H, Ueno N, Nagata K, Togo M, Terajima J, Watanabe H. 2000. Inducible stx2 phages are lysogenized in the enteroaggregative and other phenotypic Escherichia coli O86:HNM isolated from patients. FEMS Microbiol Lett 191:7-10. http://dx.doi.org/10.1111/j.1574-6968.2000.tb09311.x.
20. Morabito S, Karch H, Mariani-Kurkdjian P, Schmidt H, Minelli F, Bingen E, Caprioli A. 1998. Enteroaggregative, Shiga toxin-producing Escherichia coli O111:H2 associated with an outbreak of hemolytic-uremic syndrome. J Clin Microbiol 36:840-842.
21. Prager R, Lang C, Aurass P, Fruth A, Tietze E, Flieger A. 2014. Two Novel EHEC/EAEC hybrid strains isolated from human infections. PLoS One 9:e95379. http://dx.doi.org/10.1371/journal.pone.0095379.
22. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL. 1999. Associations between virulence factors of Shiga toxinproducing Escherichia coli and disease in humans. J Clin Microbiol 37: 497-503.
23. Persson S, Olsen KE, Ethelberg S, Scheutz F. 2007. Subtyping method for Escherichia coli Shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol 45:2020-2024. http://dx.doi .org/10.1128/JCM.02591-06.
24. Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, Ammon A, Karch H. 2002. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 185:74-84. http://dx.doi.org/10.1086/338115.
25. Bielaszewska M, Kock R, Friedrich AW, von Eiff C, Zimmerhackl LB, Karch H, Mellmann A. 2007. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS One 2:e1024. http://dx.doi.org/10.1371/journal.pone.0001024.
26. Friedrich AW, Zhang W, Bielaszewska M, Mellmann A, Kock R, Fruth A, Tschape H, Karch H. 2007. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin Infect Dis 45:39-45. http://dx .doi.org/10.1086/518573.
27. Haugum K, Brandal LT, Lindstedt BA, Wester AL, Bergh K, Afset JE. 2014. PCR-based detection and molecular characterization of Shiga toxinproducing Escherichia coli strains in a routine microbiology laboratory over 16 years. J Clin Microbiol 52:3156-3163. http://dx.doi.org/10.1128/JCM.00453-14.
28. Todd WT, Dundas S. 2001. The management of VTEC O157 infection. Int J Food Microbiol 66:103-110. http://dx.doi.org/10.1016/S0168-1605(00)00527-4.
29. Vallières E, Saint-Jean M, Rallu F. 2013. Comparison of three different methods for detection of Shiga toxin-producing Escherichia coli in a tertiary pediatric care center. J Clin Microbiol 51:481-486. http://dx.doi.org/10.1128/JCM.02219-12.
30. de Boer RF, Ott A, Kesztyus B, Kooistra-Smid AM. 2010. Improved detection of five major gastrointestinal pathogens by use of a molecular screening approach. J Clin Microbiol 48:4140-4146. http://dx.doi.org/10 .1128/JCM.01124-10.
31. Lede IO, Kraaij-Dirkzwager MM, van den Kerkhof JHTC, Notermans DW. 2012. Lack of uniformity with notifications of Shiga-toxin producing Escherichia coli and Shigella towards and by community health services. Infectieziekten Bulletin 23:116-118. (In Dutch.)
32. Scheutz F, Teel LD, Beutin L, Pierard D, Buvens G, Karch H, Mellmann A, Caprioli A, Tozzoli R, Morabito S, Strockbine NA, Melton-Celsa AR, Sanchez M, Persson S, O'Brien AD. 2012. Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing stx nomenclature. J Clin Microbiol 50:2951-2963. http://dx.doi.org/10.1128/JCM.00860-12.
33. Brandt SM, King N, Cornelius AJ, Premaratne A, Besser TE, On SL. 2011. Molecular risk assessment and epidemiological typing of Shiga toxin-producing Escherichia coli by using a novel PCR binary typing system. Appl Environ Microbiol 77:2458-2470. http://dx.doi.org/10.1128/AEM .02322-10.
34. Girardeau JP, Dalmasso A, Bertin Y, Ducrot C, Bord S, Livrelli V, Vernozy-Rozand C, Martin C. 2005. Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates. J Clin Microbiol 43: 6098-6107. http://dx.doi.org/10.1128/JCM.43.12.6098-6107.2005.
35. Toma C, Martinez Espinosa E, Song T, Miliwebsky E, Chinen I, Iyoda S, Iwanaga M, Rivas M. 2004. Distribution of putative adhesins in different seropathotypes of Shiga toxin-producing Escherichia coli. J Clin Microbiol 42:4937-4946. http://dx.doi.org/10.1128/JCM.42.11.4937-4946.2004.
36. Wickham ME, Lupp C, Mascarenhas M, Vazquez A, Coombes BK, Brown NF, Coburn BA, Deng W, Puente JL, Karmali MA, Finlay BB. 2006. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J Infect Dis 194:819-827. http://dx.doi.org/10.1086/506620.
37. van Duynhoven YT, Friesema IH, Schuurman T, Roovers A, van Zwet AA, Sabbe LJ, van der Zwaluw WK, Notermans DW, Mulder B, van Hannen EJ, Heilmann FG, Buiting A, Jansen R, Kooistra-Smid AM. 2008. Prevalence, characterisation and clinical profiles of Shiga toxinproducing Escherichia coli in The Netherlands. Clin Microbiol Infect 14: 437-445. http://dx.doi.org/10.1111/j.1469-0691.2008.01963.x.
38. Friedrich AW, Borell J, Bielaszewska M, Fruth A, Tschape H, Karch H. 2003. Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease. J Clin Microbiol 41:2448-2453. http://dx.doi.org/10.1128/JCM.41.6.2448-2453 .2003.
39. Bielaszewska M, Friedrich AW, Aldick T, Schurk-Bulgrin R, Karch H. 2006. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin Infect Dis 43:1160-1167. http://dx.doi.org/10.1086/508195.
40. Beutin L, Krause G, Zimmermann S, Kaulfuss S, Gleier K. 2004. Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J Clin Microbiol 42:1099-1108. http://dx.doi.org/10.1128/JCM.42.3.1099-1108.2004.
41. Buvens G, De Gheldre Y, Dediste A, de Moreau AI, Mascart G, Simon A, Allemeersch D, Scheutz F, Lauwers S, Pierard D. 2012. Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels Capital Region, Belgium, in 2008 to 2010. J Clin Microbiol 50:1336-1345. http://dx.doi.org/10.1128/JCM.05317-11.
42. Friesema I, van der Zwaluw K, Schuurman T, Kooistra-Smid M, Franz E, van Duynhoven Y, van Pelt W. 2014. Emergence of Escherichia coli encoding Shiga toxin 2f in human Shiga toxin-producing E. Coli (STEC) infections in the Netherlands, January 2008 to December 2011. Euro Surveill 19:26-32. http://www.eurosurveillance.org/ViewArticle .aspx?ArticleId-20787.
43. Prager R, Fruth A, Siewert U, Strutz U, Tschape H. 2009. Escherichia coli encoding Shiga toxin 2f as an emerging human pathogen. Int J Med Microbiol 299:343-353. http://dx.doi.org/10.1016/j.ijmm.2008.10.008.
44. Bosilevac JM, Koohmaraie M. 2011. Prevalence and characterization of non-O157 shiga toxin-producing Escherichia coli isolates from commercial ground beef in the United States. Appl Environ Microbiol 77:2103-2112. http://dx.doi.org/10.1128/AEM.02833-10.
45. Martinez-Castillo A, Quiros P, Navarro F, Miro E, Muniesa M. 2013. Shiga toxin 2-encoding bacteriophages in human fecal samples from healthy individuals. Appl Environ Microbiol 79:4862-4868. http://dx.doi .org/10.1128/AEM.01158-13.
46. Hirvonen JJ, Siitonen A, Kaukoranta SS. 2012. Usability and performance of CHROMagar STEC medium in detection of Shiga toxinproducing Escherichia coli strains. J Clin Microbiol 50:3586-3590. http://dx.doi.org/10.1128/JCM.01754-12.
47. Wylie JL, Van Caeseele P, Gilmour MW, Sitter D, Guttek C, Giercke S. 2013. Evaluation of a new chromogenic agar medium for detection of Shiga toxin-producing Escherichia coli (STEC) and relative prevalences of O157 and non-O157 STEC in Manitoba, Canada. J Clin Microbiol 51: 466-471. http://dx.doi.org/10.1128/JCM.02329-12.
48. Tzschoppe M, Martin A, Beutin L. 2012. A rapid procedure for the detection and isolation of enterohaemorrhagic Escherichia coli (EHEC) serogroup O26, O103, O111, O118, O121, O145, and O157 strains and the aggregative EHEC O104:H4 strain from ready-to-eat vegetables. Int J Food Microbiol 152:19-30. http://dx.doi.org/10.1016/j.ijfoodmicro.2011.10.009.
49. Hauswaldt SI, Rodloff AC, Solbach W, Knobloch JKM. 2012. Improving diagnostics of diarrheagenic Escherichia coli by use of a new chromogenic medium, poster P1760. 22nd European Congress of Clinical Microbiology and Infectious Diseases, London, United Kingdom. http://www .chromagar.com/fichiers/1336122885ECCMID-Poster-STEC-Hauswaldt .pdf.
50. Schmidt H, Scheef J, Huppertz HI, Frosch M, Karch H. 1999. Escherichia coli O157:H7 and O157:H(-) strains that do not produce Shiga toxin: phenotypic and genetic characterization of isolates associated with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol 37:3491-3496.
51. Simms I, Gilbart VL, Byrne L, Jenkins C, Adak GK, Hughes G, Crook PD. 2014. Identification of verocytotoxin-producing Escherichia coli O117:H7 in men who have sex with men, England, November 2013 to August 2014. Euro Surveill 19:pii-20946. http://www.eurosurveillance .org/ViewArticle.aspx?ArticleId-20946.